Total Health

Dr Anthony Fauci

Director, NIAID

Dr Anthony Fauci is director of the National Institute of Allergy and Infectious Diseases (NIAID) at the U.S. National Institutes of Health, where he oversees an extensive research portfolio focused on infectious and immune-mediated diseases. He serves as one of the key advisors to the White House and Department of Health and Human Services on global HIV/AIDS issues, and on initiatives to bolster medical and public health preparedness against emerging infectious disease threats. He is the winner of numerous prestigious awards including the Presidential Medal of Freedom, the National Medal of Science and the Lasker Award for Public Service.

Dr Francis Collins

Director, National Institute of Health

Francis S. Collins, M.D., Ph.D. was appointed the 16th Director of the National Institutes of Health (NIH) by President Barack Obama and confirmed by the Senate. He was sworn in on August 17, 2009. In 2017, President Donald Trump asked Dr. Collins to continue to serve as the NIH Director. President Joe Biden did the same in 2021.  Dr. Collins is the only Presidentially appointed NIH Director to serve more than one administration. In this role, Dr. Collins oversees the work of the largest supporter of biomedical research in the world, spanning the spectrum from basic to clinical research. 

Dr. Collins is a physician-geneticist noted for his landmark discoveries of disease genes and his leadership of the international Human Genome Project, which culminated in April 2003 with the completion of a finished sequence of the human DNA instruction book. He served as director of the National Human Genome Research Institute at NIH from 1993-2008.

Dr. Collins is an elected member of both the National Academy of Medicine and the National Academy of Sciences, was awarded the Presidential Medal of Freedom in November 2007, and received the National Medal of Science in 2009. In 2020, he was elected as a Foreign Member of the Royal Society (UK) and was also named the 50th winner of the Templeton Prize, which celebrates scientific and spiritual curiosity.

Lloyd Dean

CEO, CommonSpirit Health

Lloyd’s accountabilities include leading CommonSpirit Health’s hospital and clinical operations, financial strategy and human resources for 150,000 employees across more than 1,000 care sites, including 137 hospitals. He previously served as President and Chief Executive Officer of Dignity Health since 2000. His current board memberships include the Cal Poly Foundation of California Polytechnic State University, Carnegie Hall, the California Future Health Workforce Commission, and the Committee on Jobs. Lloyd received a bachelor’s degree in sociology and a master’s degree in educational leadership from Western Michigan University, Kalamazoo; and an honorary doctorate degree in humane letters from the University of San Francisco.

Dr. Vivek H. Murthy

Surgeon General of the United States

Dr. Vivek H. Murthy served as the 19th Surgeon General of the United States from December 15, 2014 to April 21, 2017 and was confirmed by the United States Senate on March 23, 2021 as the 21st Surgeon General of the United States.

In his first term as America’s Doctor, Dr. Murthy created initiatives to tackle our country’s most urgent public health issues. He chose areas of focus that were raised by people across America during his inaugural listening tour. Highlights included:

• Facing Addiction in America: The Surgeon General’s Report on Alcohol, Drugs, and Health - the nation’s first Surgeon General’s Report presenting the latest scientific data on addiction and issuing a call to action to the nation to recognize addiction as a chronic illness and not a moral failing.
• TurnTheTideRx: The Surgeon General’s Call to End the Opioid Crisis - In 2016, Dr. Murthy sent a letter to 2.3 million health care professionals urging them join a movement to tackle the opioid epidemic. This was first time in the history of the office that a Surgeon General had issued a letter calling the medical profession to action.
• Surgeon General’s Report on E-cigarette Use Among Youth - First federal report on e-cigarettes, highlighting the health risks of e-cigarette use for youth
• Step It Up! The Surgeon General’s Call to Action to Promote Walking and Walkable Communities - Launched efforts to increase physical activity in communities across the country, including a two-week public-private partnership with Fitbit that engaged over 600,000 people to take an industry record-setting 60 billion steps.
• Get Vaccinated with the Surgeon General and Elmo: Partnered with Elmo in a popular video that demystifies vaccines for parents and children

In 2017, Dr. Murthy focused his attention on chronic stress and isolation as prevalent problems that have profound implications for health, productivity, and happiness. Partnering with the Veterans Health Administration, he led a convening that brought together leading thinkers, researchers, and practitioners to identify scientifically proven ways we can cultivate emotional well-being and fitness to help us thrive among the most challenging circumstances.

In addition to his role as America’s Doctor, as the Vice Admiral of the U.S. Public Health Service Commissioned Corps, Dr. Murthy commanded a uniformed service of 6,600 public health officers, serving the most underserved and vulnerable populations in over 800 locations domestically and abroad. He worked with thousands of Commissioned Corps officers to strengthen the Corps and protect the nation from Ebola and Zika and to respond to the Flint water crisis, major hurricanes, and frequent health care shortages in rural communities.

Dr. Murthy’s commitment to medicine and health began early in life. The son of immigrants from India, he discovered the art of healing watching his parents - Hallegere and Myetriae Murthy - treat patients like family in his father’s medical clinic in Miami, Florida. Prior to becoming Surgeon General, his accomplishments included:

• VISIONS: Co-founded with his sister, Rashmi, a peer-to-peer HIV/AIDS education program in India and the United States that reached tens of thousands of students.
• Swasthya Project: Co-founded a community health partnership that trained women to defy the odds in their patriarchal villages and become health care providers and educators.
• TrialNetworks: Co-founded a software technology company that improves research collaboration in clinical trials and is powering research studies around the world.
• Doctors for America: Co-founded a nonprofit with more than 18,000 physician and medical student members from all 50 states dedicated to creating a high quality, affordable health care system for all. 
• Medical care and education: Cared for thousands of patients and trained hundreds of medical students and residents.
• Research: Conducted basic science research on vaccines and health care services research focused on the participation of women and minorities in clinical trials. His research and perspectives have been published in the nation’s top medical journals.  

In 2020, Dr. Murthy authored the New York Times Bestselling Book, Together: The Healing Power of Human Connection in a Sometimes Lonely World.

Dr. Murthy received his bachelor’s degree from Harvard and his M.D. and M.B.A. degrees from Yale. He completed his internal medicine residency at Brigham and Women’s Hospital in Boston and later joined Harvard Medical School as faculty in internal medicine. 

Dr. Murthy resides in Washington, D.C. with his wife, Dr. Alice Chen, and their two young children.

Stephane Bancel

CEO, Moderna

Stéphane Bancel has served as Moderna's Chief Executive Officer since October 2011 and as a member of Moderna’s board of directors since March 2011. Before joining the Company, Mr. Bancel served for five years as Chief Executive Officer of the French diagnostics company bioMérieux SA. From July 2000 to March 2006, he served in various roles at Eli Lilly and Company, including as Managing Director, Belgium and as Executive Director, Global Manufacturing Strategy and Supply Chain. Prior to Lilly, Mr. Bancel served as Asia-Pacific Sales and Marketing Director for bioMérieux.

Mr. Bancel currently serves on the board of directors of Qiagen N.V. and Indigo. He is currently a Venture Partner at Flagship Pioneering and a trustee of the Museum of Science in Boston. Mr. Bancel holds a Master of Engineering degree from École Centrale Paris (ECP), a Master of Science in chemical engineering from the University of Minnesota, and an M.B.A. from Harvard Business School.

Dr Vas Narasimhan

CEO, Novartis

Since becoming CEO of Novartis in 2018, Vas has led a strategic and cultural transformation to build a leading medicines company powered by advanced therapy platforms and data science. He leads a company of more than 100,000 associates that does business in approximately 155 countries and that reached 769 million patients with its medicines in 2020.

Vas has focused his education and career on improving human health and on his personal purpose of inspiring a healthier world. During and after his medical studies, he worked on public health issues such as HIV/AIDS, malaria and tuberculosis in India, Africa and South America. He continues to champion access and global health priorities, including through a commitment by Novartis to expand access to innovative medicines in low- and middle-income countries by at least 200% by 2025.

Dr Rod Hochman

President and CEO, Providence St Joseph

Rod Hochman, M.D., is the president and CEO of Providence St. Joseph Health, a Catholic not-for-profit health system. PSJH has served the Western U.S. for more than 165 years and together include 119,000 caregivers who serve in 51 hospitals, nearly 1,000 clinics and hundreds of programs and services in Alaska, California, Montana, New Mexico, Oregon, Texas and Washington. Under Rod’s leadership, Providence St. Joseph Health is transforming health care for the future through digital innovation, population health, mental health, genomics, whole person care and outreach to the poor and vulnerable.

He is the chair elect designate for for the American Hospital Association (AHA), chair of AHA's Regional Policy Board 9 and past chair of the board of trustees for the Catholic Health Association. He is the 2019 recipient of the Gail L. Warden Leadership Excellence Award by the National Center on Healthcare Leadership. He tied for second place in Modern Healthcare's most influential person's in health care ranking in 2018 and was named one of Modern Healthcare's 12 disruptors. He was also named the 2015 Innovator of the Year by Press Ganey and the 2017 Partners in Care Foundation Vision and Excellence in Health Care Leadership Award. Rod is actively involved in Providence Health International and has traveled to Guatemala to strengthen Providence St. Joseph Health’s local relationships to continue to improve the health of Guatemalan communities in a sustainable way. He is passionate about drawing on the diverse resources and talents of Providence St. Joseph Health’s seven-state health system to touch lives wherever relief, comfort and care are needed most.

Rod served as a clinical fellow in internal medicine at Harvard Medical School and Dartmouth Medical School. In addition, he is a Fellow of the American College of Physicians and a Fellow of the American College of Rheumatology. He received his bachelor’s degree and medical degree from Boston University.

Dr Penny Wheeler

CEO, Allina Health

Penny Wheeler, MD, is chief executive officer of Allina Health. Before she was appointed CEO, she served as president and chief clinical officer of Allina Health, responsible for leading the organization's quality and value agenda through alignment of the clinical and operational leadership to optimally benefit those served by Allina Health. A board-certified obstetrician/gynecologist, Dr. Wheeler served patients at Women's Health Consultants in Minneapolis, was the president of Abbott Northwestern Hospital's medical staff, chaired the Allina Health Quality Committee and served on the Allina Health Board of Directors.

Dr. Wheeler sets the overall strategic direction for Allina Health, focusing on ensuring that the organization delivers exceptional care and supports the health and well-being of all those served.

Under Dr. Wheeler’s leadership, Allina Health has sharpened its focus on serving those who have not always been well-served by the health care system, including individuals with disabilities through the creation of Courage Kenny Rehabilitation Institute; those with mental illness and addiction issues through significant investments in Allina Health’s mental health capabilities.

Dr. Wheeler serves on the board of Portico Healthnet, an organization dedicated to helping uninsured Minnesotans receive affordable health coverage and care, St. Thomas University, the University of Minnesota Foundation, and is the incoming chair of the American Hospital Association’s System Council. She was also named to the Board of Cedar, an organization that eases the strain of financial billing for those served.

Modern Healthcare recognized Dr. Wheeler as one of the top 25 women in health care. In addition, she received an award as one of the 100 most influential people in health care and was recognized as one of the 50 most influential clinical executives.

Her educational background includes an undergraduate degree with honors from the University of Minnesota and a doctorate of medicine degree from the University of Minnesota Medical School.

Bob Bradway

Chairman and CEO, Amgen

Robert A. Bradway is Amgen’s chairman and chief executive officer. He became chairman in January 2013 and chief executive officer in May 2012. Bradway served as the company’s president and chief operating officer from May 2010 to May 2012, and was appointed to the Amgen Board of Directors in October 2011. He joined the company in 2006 as vice president, Operations Strategy, and served as executive vice president and chief financial officer from April 2007 to May 2010.

Prior to joining Amgen, Bradway was a managing director at Morgan Stanley in London where, beginning in 2001, he had responsibility for the firm’s banking department and corporate finance activities in Europe. He joined Morgan Stanley in New York as a health care industry investment banker in 1985 and moved to London in 1990.

Bradway is a member of the board of directors of The Boeing Company, chairing its Finance committee and serving on its Audit committee. He also serves as a board member of the W. M. Keck Foundation, the Pharmaceutical Research and Manufacturers of America (PhRMA), and the CEO Roundtable on Cancer, a non-profit organization dedicated to advancing cancer treatment and prevention. In addition, Bradway serves on the board of trustees of the University of Southern California, and he is a member of the American Heart Association CEO Roundtable, which is helping the Association meet its goal of improving the cardiovascular health of all Americans.

Bradway holds a bachelor’s degree in biology from Amherst College and a master’s degree in business administration from Harvard University.

Kim Keck

President and CEO, Blue Cross Blue Shield Association

Kim A. Keck is president and chief executive officer of the Blue Cross Blue Shield Association (BCBSA), a national federation of 35 independent, community-based and locally operated Blue Cross and Blue Shield (BCBS) companies. Today, one in three Americans is covered by the Blue System. 

Keck, a respected leader in the healthcare industry, has built a reputation as an engaged, incisive leader. Prior to joining BCBSA in 2021, she served as president and CEO of Blue Cross & Blue Shield of Rhode Island (BCBSRI), the state’s largest health insurer. During her tenure at BCBSRI, she drove strategic initiatives around cost and value stewardship, convenience and comprehensive health, and led policy efforts fortifying elements of the Affordable Care Act to ensure all Rhode Islanders have access to quality care. She also combatted long-standing social issues influencing health outcomes, including childhood obesity, housing insecurity and racial inequities.  

Keck previously spent 28 years at Aetna, where she held leadership roles spanning from head of enterprise strategy to head of investor relations, treasury, tax, actuary, controllers and planning. She served as president of Aetna’s northeast region and interim president of the southeast region and was responsible for $20 billion in revenue and approximately five million members across the commercial and Medicare segments.  

Keck graduated with honors from Boston College with a degree in mathematics and earned a Master of Business Administration in finance from the University of Connecticut. She is a CFA charter holder.  

Keck serves on the boards of directors of Oak Street Health and Evolent Health. She is a frequent speaker on topics related to healthcare policy and women’s leadership.

Kristen Helton

GM, Amazon Care

Bio coming soon.

Dr. Anne Klibanski

President and CEO, Mass General Brigham

Anne Klibanski, M.D., is the President and Chief Executive Officer of Mass General Brigham, a Boston-based integrated health care system that includes internationally known Brigham and Women’s Hospital and Massachusetts General Hospital, nationally recognized specialty hospitals, including Mass Eye and Ear, McLean, and Spaulding Rehabilitation, seven community hospitals, a health insurance company, physician networks, community health centers, home care, and long-term care services. 

As the largest private employer in Massachusetts with 78,000 employees and annual revenue of $13.4 billion, the non-profit health care system is the nation’s leading recipient of National Institutes of Health funding and is a principal teaching affiliate of Harvard Medical School, establishing the health care system’s position as a national leader in medical research and teaching. 

Appointed to her role as President and CEO in June 2019, Dr. Klibanski’s vision for Mass General Brigham is to build the integrated academic health care system of the future with patients at the center, transforming care, improving outcomes, and expanding impact locally, nationally, and globally. 

Dr. Klibanski has served as the health care system’s Chief Academic Officer and as Chief of Neuroendocrine at Massachusetts General Hospital. She is recognized internationally for her high-impact research in neuroendocrine disorders and pituitary tumors. 

Dr. Klibanski received her B.A., magna cum laude in literature from Barnard College and her M.D. from New York University Medical Center. She is the Laurie Carrol Guthart Professor of Medicine at Harvard Medical School.

David Holmberg

President and CEO, Highmark Health

David L. Holmberg is president and chief executive officer of Highmark Health, a $21 billion blended health organization that includes one of America’s largest Blue Cross Blue Shield insurers and a growing regional hospital and physician network. Based in Pittsburgh, PA, Highmark Health’s 35,000 employees serve millions of customers nationwide through the nonprofit organization’s affiliated businesses, including Highmark Inc., Allegheny Health Network, HM Insurance Group, United Concordia Dental, and HM Health Solutions.

One of the nation’s most influential and transformative health care executives, Holmberg is helping to shape the future of this fast-evolving industry. He has proactively and regularly engaged with trade associations, regulators, peer organizations, strategic partners, and government entities — both regional and national — to resolve critical health care issues and ensure the equitable treatment of Highmark Health’s patients, policyholders, and business customers. In 2016, Highmark Health sued the U.S. government in federal claims court, resulting in a 2020 Supreme Court ruling that affirmed that the federal government must fulfill its promises to preserve the trust that makes successful public-private partnerships, including the ACA marketplace, possible.

Holmberg joined Highmark Inc. in 2007 and served in a series of executive positions, including president of its Diversified Businesses, where he was responsible for businesses representing more than $3.5 billion in revenue, chief executive officer for HVHC Inc. and chief executive officer and chairman for HM Insurance Group, United Concordia Dental and San Antonio, Texas-based Visionworks, which was divested in 2016 for $1.6 billion.

Under Holmberg’s leadership, Highmark Health successfully navigated the tumultuous post-ACA years as well as the financial turnaround of Allegheny Health Network, which was nearing bankruptcy when it was acquired by Highmark Inc. in 2013. In addition to delivering 11 consecutive quarters of positive operating income prior to the COVID 19 pandemic, the health delivery system has expanded to include 12 hospitals in western Pennsylvania, as well as five multi-specialty medical malls. In 2019, Holmberg successfully negotiated an agreement with the Pennsylvania Attorney General to provide residents of western Pennsylvania with continued access to the region’s two leading health systems.

In early 2020, Highmark Health’s financial strength and stability enabled the rapid deployment of resources needed to diagnose, treat and support the organization’s members and patients through the COVID 19 pandemic. It has also enabled the implementation of a bold transformation strategy designed to lead the change in the health care experience for consumers by providing affordable, accessible, high-quality, community-based medicine and coverage options. The 2020 COVID-19 pandemic accelerated that strategy due to Highmark Health’s differentiated position in the industry as a vertically integrated payer-provider.

Michael Neidorff

Chairman, President and CEO, Centene

Michael Neidorff is Centene Corporation's chairman, president and chief executive officer. A recognized leader in the industry, he is committed to building a multi-national healthcare enterprise while upholding Centene's local approach to healthcare. He demonstrates a history of successfully implementing programs and services under Medicaid, Medicare, and commercial managed care. Under his leadership, Centene has grown from a $40 million corporation to a publicly traded (NYSE: CNC), FORTUNE® 100, diversified, healthcare enterprise.

Michael Neidorff became president and chief executive officer of Centene Corporation in 1996. The company established operations in all 50 states – to become the largest Medicaid managed care organization in the U.S. and the top insurer in the Health Insurance Marketplace. Revenues are expected to exceed $110 billion in 2020. Centene now delivers high-quality and accessible healthcare to nearly 1 in 15 individuals across the nation.

Centene provides accessible, cost-effective coverage to the rising number of under-insured and uninsured people in communities across the U.S. Under Mr. Neidorff's leadership, Centene has expanded from operating Medicaid health plans solely in Wisconsin and Indiana, to operations in every state, serving more than 23 million managed care and TRICARE eligible individuals.

Mr. Neidorff's record of transformative leadership is proven in the healthcare industry. In 1985, he started Physicians Health Plan of Greater St. Louis, a subsidiary of UnitedHealth Group. He served as the president and chief executive officer from 1985-1995, and grew the plan to be one of UnitedHealth Group's most successful and profitable plans in the country. From 1995-1996, he served as the regional vice president of Coventry Health Care, Inc., a publicly traded managed care organization, and as the president and chief executive officer of one of its subsidiaries, Group Health Plan Inc. in St. Louis. He also served in international senior executive positions at Miles Laboratories/Bayer AG.

Michael Neidorff dedicates significant time to civic organizations. He is a board member of the National Urban League and served as its chairman from 2014-2019. In 2015, he was inducted into the Hall of Fame for Junior Achievement of Greater St. Louis. He served as a member of the board of directors for the Greater St. Louis Boy Scouts of America since 1990, serving as Pathfinder district chair, vice chairman and chairman of the Special Needs Committee, vice president of Finance, and council president. Mr. Neidorff is a member of the board of trustees for Trinity University in San Antonio, Texas, his alma mater, and previously served as chairman of the board.

Karen Ignagni

President and CEO, Emblem Health

Karen Ignagni serves as President and Chief Executive Officer of the EmblemHealth family of companies.

EmblemHealth has protected access to quality care for essential workers, small and large businesses, and Medicare and Medicaid beneficiaries through its health plans, EmblemHealth and ConnectiCare for over 80 years. It has built a network of over 40 primary and specialty physician practices through AdvantageCare Physicians and BronxDocs. EmblemHealth Health@Work plays a critical role in serving the occupational health needs of eastern New York and EmblemHealth Family Dental Practices serve New York State workers. EmblemHealth recently launched WellSpark, a national wellness company focused on bridging the gap between physical and mental wellness.

During her tenure as CEO and President, Ms. Ignagni has led an unprecedented modernization effort with a relentless focus on the customer experience. EmblemHealth’s growth and expansion of services has led to many accolades for her leadership in the health care industry, earning recognition by leading publications including the New York Times, City and State, Modern Healthcare, Crain’s, National Journal, Time Magazine, and Fortune Magazine.

In 2021, Ms. Ignagni was once again named one of City & State New York’s Labor Power 100 and City & State New York’s Health Power 100. In 2020, Ms. Ignagni was recognized for her work by several publications including, Crain’s New York Business’ Notable in Health Care leaders, City & State New York’s Health Power 100, Labor Power 100, and Women’s Power 100 and was named one of Becker’s Hospital Review’s 2020 Women to Watch in Health IT. In 2019, Ms. Ignagni was named one of Crain’s New York Business’ 50 Most Powerful Women in New York and was on the list of City & State New York’s Labor Power 100, The Responsible 100, and Women Power 100. She serves on the Governor’s Council on Women and Girls, the New York Department of Financial Services (DFS) State Insurance Advisory Board, the New York Department of Financial Services (DFS) State Insurance Women Leadership Committee and also on the New York State Department of Health’s Marketplace Advisory Committee. In 2018, she was named one of Crain’s New York Business’ Notable Women in Health Care, named one of Becker’s Hospital Review’s Female Health IT Leaders to Know and was on the list of City & State New York’s Women Power 100. From 2017 – 2019, Ms. Ignagni served as Chair of Columbia University’s National Board of Advisors for Health Policy and Management at the Mailman School of Public Health. From 2016 – November 2019, she served on the U.S. Department of Veteran’s Affairs Special Medical Advisory Committee.

Prior to joining EmblemHealth in 2015, Ms. Ignagni was President and CEO of America’s Health Insurance Plans (AHIP), the insurance industry association that represents providers of health and supplemental benefits to more than 200 million Americans. Under her leadership, AHIP became the leading voice for the health plan community.

Ms. Ignagni also directed the AFL-CIO’s Department of Employee Benefits. She was a Professional Staff Member on the U.S. Senate Labor and Human Resources Committee and worked at the U.S. Department of Health and Human Services.

Ms. Ignagni resides in New York City with her husband.

Dr. Susan Turney

President and CEO, Marshfield Clinic

Dr. Susan L. Turney is the CEO of Marshfield Clinic Health System (MCHS), taking on that role September 1, 2014. Through its entities, MCHS provides patient care, research, education, health care technology and health insurance for Wisconsin and beyond.

She is recognized as a national thought leader in health care and expert in strategic planning, executive management and external relations. She is sought out as a speaker by national organizations to discuss the business of this industry and is a member of the Modern Healthcare CEO Power Panel, including representatives of the nation’s largest hospital, physician practice, insurer, trade association and think tank organizations.  She was named to Modern Healthcare’s list of 50 Most Influential Physician/Clinical Executives from 2012-2016, 2018, 2019, 2020 and on its list of 100 Most Influential People in Healthcare in 2012- 2014, and 2019. Dr. Turney received the Wisconsin Medical Society’s Directors Award in 2017.  She was named to Becker’s Hospital Review’s list of 27 Female Physician Executives to know in 2018 and named Distinguished Leader by MGMA-ACMPE in 2018. Dr. Turney was named to Becker’s Hospital Review’s list of 105 Physician Leaders to Know in 2019.

Prior to her current MCHS position, Dr. Turney was President and CEO, Medical Group Management Association (MGMA), the leading association for medical group practice administrators and executives, from 2011-14. She was CEO and Executive VP of the Wisconsin Medical Society from 2004-11.  She is a Fellow in the American College of Medical Practice Executives (FACMPE), having earned that distinction in 2005.

For 22 years, from 1982-2004, Dr. Turney was an internal medicine physician at Marshfield Clinic, serving in education and leadership roles and as medical director for Patient Financial Services from 1995 to 2004.

Dr. Turney, a native of Mellen, Wisconsin, graduated from Northland College, Ashland, Wisconsin; and the University of Wisconsin-Madison School of Medicine and Public Health. She completed her internal medicine residency at Marshfield Clinic/Ministry Saint Joseph’s Hospital, Marshfield, Wisconsin, and earned a masters degree in administrative medicine from UW-Madison.

Nancy Howell Agee

President and CEO, Carilion Clinic

Nancy Howell Agee is president and chief executive officer of Carilion Clinic, a nearly $2 billion not-for-profit integrated health system headquartered in Roanoke, Virginia, serving more than 1 million people in Virginia and West Virginia.

Carilion Clinic includes seven hospitals ranging from the third largest in Virginia to mid-sized community and small rural or critical access hospitals. Carilion also operates complementary business lines, including home health, imaging services, pharmacies and free-standing surgical clinics and has a large physician group with more than 1,000 employed physicians.

Before becoming CEO in 2011, Ms. Agee served as executive vice president and chief operating officer. During her tenure as COO, she co-led Carilion’s reorganization from a collection of hospitals to a fully integrated, physician-led clinic. The reorganization resulted in a partnership with Virginia Tech to create an allopathic medical school and research institute.

Ms. Agee is recognized nationally as a health care leader and currently serves as chair of the American Hospital Association, a membership organization representing the nation’s 5,000 hospitals and health care systems. She was named one of Modern Healthcare’s top 25 women in health care in 2017 and one of the national magazine’s 100 most influential people in health care in 2016 and 2017. She is a former member of The Joint Commission’s Board of Commissioners and past chair of the Virginia Hospital & Healthcare Association and the Virginia Center for Health Innovation.

David Entwistle

President and CEO, Stanford Health

David Entwistle is President and CEO of Stanford Health Care (SHC), where he has served since 2016. Among other achievements, Entwistle has championed the development and implementation of an integrated strategic plan that aligns SHC, the Stanford School of Medicine, and Stanford Children’s Health behind a common vision and key strategic initiatives through 2025. Under his leadership, SHC has also received a number of national accolades, including being named a top-10 U.S. academic medical center for care quality by Vizient. Most recently, Entwistle spearheaded the completion of the new Stanford Hospital, which opened to patients in November 2019, representing the culmination of more than a decade of planning, design, and construction.

Entwistle has extensive executive experience at leading academic medical centers. Previously, he served as CEO of the University of Utah Hospital & Clinics (UUHC) for nine years. UUHC is the only academic medical center in the Intermountain West region, with 1,100 board-certified physicians who staff four university hospitals, 10 community clinics and several specialty centers. While at UUHC, the organization earned a number of prestigious awards, including a No. 1 national ranking by Vizient in its annual Quality and Accountability Study of U.S. academic medical centers. For his administrative contributions to UUHC and for his long-standing track record in quality achievement, Entwistle received the Modern Healthcare “Up and Comers Award” in 2008.

Prior to UUHC, Entwistle served as Senior Vice President and Chief Operating Officer of the University of Wisconsin Hospital and Clinics in Madison, Wisconsin from 2002-2007. He was also the former Vice President of Professional Services and Joint Venture Operations at City of Hope National Medical Center in Duarte, California.

As a recognized health care thought leader, Entwistle is a board member of the American Hospital Association, the AAMC Council of Teaching Hospitals, the Accreditation Council for Graduate Medical Education and Vizient (formerly University HealthSystem Consortium). He is the past chair of the Utah Hospital Association and was appointed by the governor of Utah to the state’s Medicaid Task Force.

He earned a bachelor's degree in Health Sciences from Brigham Young University and a master’s degree in Health Services Administration from Arizona State University. He also was awarded a postgraduate administrative fellowship at the University of Texas M.D. Anderson Cancer Center.

Carl Armato

President and CEO, Novant Health

Carl S. Armato is president and chief executive officer of Novant Health. He joined Novant Health in 1998 as vice president of finance and operations for physician divisions in both Charlotte and Winston-Salem, North Carolina. Armato has also served as senior vice president of materials management and logistics for Novant Health. In 2003, Novant Health Presbyterian Medical Center appointed Armato as chief operating officer and later promoted him to president and CEO in January 2004. He became president of Novant Health markets in 2008 and chief operating officer of the system in 2011. The board of trustees appointed him to his current position in January 2012.

Before joining Novant Health, Armato was vice president of operations for First Care Physicians and director of finance for General Health System in Baton Rouge, Louisiana. He was also a senior tax/audit consultant for Ernst & Young in the Baton Rouge office prior to beginning his career in healthcare. Armato holds a Bachelor of Business Administration in accounting from the University of Southwestern Louisiana and a Master of Business Administration from Norwich University of Vermont.

He is a certified public accountant licensed in Louisiana, by the State Board of CPAs of Louisiana and in North Carolina, by the North Carolina State Board of Certified Public Accountant Examiners. He is a member of the American Institute of Certified Public Accountants, the North Carolina Association of Certified Public Accountants, and the Healthcare Financial Management Association.

Armato serves on the Vizient Inc. Board of Directors as well as the Vizient Inc. Finance Committee, the American Heart Association Southeast Board of Directors, the Charlotte Executive Leadership Council, the American Hospital Association Committee on Health Care Strategy and Innovation, and the JDRF North Carolina Executive Council, where he is a founding member. His past service includes work with the North Carolina Chamber of Commerce, the American Hospital Association Governing Council, the Wall Street Journal CEO Council, Knights of Columbus, Mecklenburg Citizens for Public Education and the Friends of Scouting.

He has authored 2 books, It’s Never Just Another Monday and A Future With Hope: An Inspiring Guide to Overcoming Diabetes, in addition to multiple articles featured on CNN, The New England Journal of Medicine, and the US Chamber of Commerce Foundation.

In 2013, Armato was recognized by the Triad Business Journal as one of the Most Influential People in the Triad, and by the Public Relations Society of America, Charlotte Chapter, with the Pegasus Award. He is also a recipient of the 2015 Father of the Year Award by the American Diabetes Association, Charlotte Chapter, as well as the 2020 recipient of the Steven Schroeder Award for Outstanding Healthcare CEO from Costs of Care. Additionally, Armato has been recognized by the Triad Business Journal and Charlotte Business Journal as a Most Admired CEO.

Dr Jaewon Ryu

President and CEO, Geisinger

Dr. Jaewon Ryu is Geisinger’s president and chief executive officer. He came to Geisinger as the executive vice president and chief medical officer in 2016, and in that capacity, he has overseen all aspects of patient care at Geisinger, working to improve the quality, affordability and experience of care delivered across the enterprise.

During his tenure at Geisinger, Dr. Ryu has cultivated a spirit of innovation and transformation across the organization, driving new approaches to some of healthcare’s most complex problems. These include initiatives like primary care redesign; Geisinger at Home, which brings healthcare services to patients in their home; and 65 Forward, our senior-focused, concierge healthcare centers. All of these are examples of Dr. Ryu’s commitment to making health easier by improving outcomes, engagement and affordability. This dedication to innovation for the health of our communities earned Dr. Ryu a top 20 spot on Modern Healthcare’s Most Influential Clinical Executives list for 2019.

Dr. Ryu was previously at Humana, where he was president of integrated care delivery and responsible for Humana’s owned and joint ventured care delivery assets, including a management services organization (MSO) assisting affiliated practices to adopt population health under value-based reimbursement methodologies.

Prior to Humana, Dr. Ryu held various leadership roles at the University of Illinois Hospital & Health Sciences System, Kaiser Permanente (where he also practiced as an emergency medicine physician), and in government, at the Centers for Medicare and Medicaid Services, and as a White House Fellow at the Department of Veterans Affairs. He was also a practicing corporate healthcare attorney with the international firm McDermott, Will & Emery.

Dr. Ryu was appointed to the Medicare Payment Advisory Commission (MedPAC), an independent body legislatively tasked with advising Congress on payment and other policies governing health plans and providers serving Medicare beneficiaries. He has previously served in various other advisory roles, including board positions with My Health Direct Inc., a provider of digital care coordination solutions (acquired by Experian), as well as MCCI and JenCare, both clinic/MSO organizations managing the financing and delivery of care for Medicare Advantage members under full-risk payment models. He has also served on the Board of Directors of the White House Fellows Foundation and Association.

Dr. Ryu earned his BA degree from Yale University and his MD and JD from the University of Chicago. He completed his residency training in emergency medicine at Harbor-UCLA Medical Center.

Brian Gragnolati

President and CEO, Atlantic Health

Bio coming soon.

Clay Holderman

President and CEO, UnityPoint Health

Clay Holderman, MBA was named President and CEO of UnityPoint Health in February 2021. UnityPoint Health® provides care in nine regions throughout Iowa, western Illinois and southern Wisconsin in its hospitals, clinics and home health settings. Holderman previously held the role of Executive Vice President and Chief Operating Officer at Presbyterian Healthcare Services, a $4.8 billion integrated payor-provider health system in New Mexico, where he oversaw all care delivery operations, information technology, real estate and development, payor-provider integration and new ventures. He has held executive leadership roles in both investor-owned and not-for-profit health systems, including multiple Hospital Chief Executive Officer roles for LifePoint Hospitals and Ardent Health.

At Presbyterian, Holderman oversaw nine hospitals, an 1,100-member statewide multispecialty practice, three ambulance companies and several large home health agencies. He led the development of two de-novo hospitals and was instrumental in driving growth for the system from $2.2 billion to $4.8 billion in net revenue. He led significant initiatives in clinical service line implementation, labor and supply chain cost management, ambulatory site of service shift to lower total cost of care and a portfolio of new business development and acquisitions. Holderman also contributed to work addressing social determinants of health in order to reduce disparities in health outcomes and the cost of care for New Mexico's most vulnerable populations.

During the SARS-CoV2 pandemic, Holderman served the State of New Mexico as the Health System Advisor, organizing the state's competing hospitals into a hub and spoke model with a single transfer center for all critical care admissions statewide. He served as Presbyterian's Area Commander for the pandemic throughout 2020, including recovery of operations to near pre-pandemic levels by August 2020. Holderman is most proud of the move the leadership team initiated to elevate workforce wellbeing to a board-level strategic initiative, lifting provider satisfaction from the bottom decile to national median and workforce engagement from the 26th to 67th percentile in four years.

Dr Ed Kim

Physician-in-Chief, City of Hope Orange County

Edward S. Kim, M.D., M.B.A., Fellow of the American College of Surgeons, and Fellow of the American College of Surgeons, is physician-in-chief at City of Hope Orange County and the Vice Physician-in-Chief, City of Hope National Medical Center. Dr. Kim joins City of Hope in fulfilling its promise of enhanced local access to cancer breakthroughs by leading its esteemed team of clinicians in Orange County.

A U.S. News & World Report "Top Doctor" and clinician world-renowned for his immense oncology experience, Dr. Kim is poised to drive innovation in cancer care and delivery, developing paradigms for translating research into clinical practice and introducing new therapies for the Orange County clinical network and planned Irvine campus.

Backed by a distinguished history of pioneering cancer research, Dr. Kim is among the country's foremost experts in molecular prognostication — which advances cancer detection and personalized therapies — for lung, head and neck cancers. He's served as a principal/co-principal investigator on numerous studies and protocols and authored/co-authored more than 200 published articles, book chapters and reviews in top-tier journals, such as The Lancet, The Lancet Oncology, Journal of Clinical Oncology, Cancer Discovery, Cancer, Nature Medicine, and Cancer Prevention Research.

Before joining City of Hope, Dr. Kim was chair of Solid Tumor Oncology and Investigational Therapeutics, the Donald S. Kim Distinguished Chair for Cancer Research and medical director of the Clinical Trials Office at Levine Cancer Institute, Atrium Health, in Charlotte, North Carolina, and professor of medicine at University of North Carolina, Chapel Hill. He's held many leadership roles, such as tenured associate professor in the Department of Thoracic/Head and Neck Medical Oncology at University of Texas MD Anderson Cancer Center. Dr. Kim recently completed his Master of Business Administration at University of North Carolina Kenan-Flagler Business School.

Dr. Kim's goals for City of Hope are to promote strategic and team-oriented translational research and patient advocacy for greater accessibility and equitability in cancer care.

Eugene A. Woods

President and CEO, Atrium Health

Eugene A. Woods, MBA, MHA, FACHE, is president and chief executive officer of Atrium Health, a nationally leading, non-profit health system with more than 70,000 teammates serving patients at 42 hospitals and over 1,500 care locations across four states: North Carolina, South Carolina, Virginia and Georgia. It also includes Wake Forest Baptist Health and Wake Forest School of Medicine in Winston-Salem, North Carolina and Atrium Health Navicent in Macon, Georgia.

Woods joined Atrium Health in April 2016 and, during his tenure, Atrium Health also has been recognized as one of the Best Employers for Diversity, for new grads and for Women by Forbes; number one on the list of Best Places to Work for Women & Diverse Managers by DiversityMBA; one of the 150 Top Places to Work in Healthcare by Becker’s Healthcare; and the number one military-friendly employer in the country. In addition, the organization has been recognized by U.S. News & World Report, Leapfrog Group and the American Nurses Credentialing Center as among the very best in the nation and was honored by the American Hospital Association with the Equity of Care Award and one of the first-ever Quest for Quality honors for its Rehabilitation Hospital. Most recently, Atrium Health was recognized by the Centers for Medicare & Medicaid Services (CMS) as a 2020 CMS Health Equity Award recipient for its dedication to health equity by reducing disparities and enabling communities to achieve the highest level of health.

One of today’s most prominent leaders in healthcare, Woods served as chairman of the American Hospital Association board of trustees in 2017 and is currently chair of the Nominating Committee as well as a member of the Health, Strategy and Innovation Committee. Woods has also served as a member of The Wall Street Journal’s CEO Council, and currently serves on the Becker’s Healthcare’s Advisory Board, Scottsdale Institute’s Board of Directors, the board of Best Buy, the Executive Committee of the Healthcare Leadership Council and as chair of the board of the Federal Reserve Bank of Richmond. Woods also was appointed to the North Carolina Council for Health Care Coverage and the North Carolina Governor Roy Cooper’s Economic Recovery Task Force. And, most recently, the Governor’s Andrea Harris Social, Economic, Environmental and Health Equity Task Force to help address disparities in communities of color that have been exacerbated by the COVID-19 pandemic.

Woods has 30 years of healthcare leadership experience, and his career is decorated with many honors, including his most recent recognitions as #7 of the 100 Most Influential People in Healthcare and one of the Top 25 Minority Executives in Healthcare – as well as being one of only five “Luminaries,” honored for their career-defining work in reshaping the industry – by Modern Healthcare. He has also been named a Healthcare Pioneer for Black History Month 2021 by Governor Roy Cooper and the North Carolina African American Heritage Commission; the recipient of the Whitney M. Young Jr. award for service to the state of North Carolina by the Urban League of Central Carolinas; the recipient of the Charlotte Business Journal’s 2020 Business Person of the Year; the 2020 Distinguished 400 Award recipient by the 400 Years of African American History Commission; one of the 50 Great African American Leaders, as well as one of the 100 Great Leaders in Healthcare by Becker’s Healthcare; one of the Most Influential Blacks in Corporate America by Savoy Magazine; one of the Most Powerful Executives in Corporate America by Black Enterprise; one of the Most Admired CEOs of 2018 by the Charlotte Business Journal; one of the 2019 Power 100 honorees by Business North Carolina; Senior Executive of the Year by the National Association of Health Service Executives; and Alumni of the Year by the Pennsylvania State University.

Woods holds three degrees from the Pennsylvania State University: a bachelor’s degree in health planning and administration, a master’s degree in business administration and a master’s degree in health administration.

Jim Skogsbergh

President and CEO, Advocate Aurora

Jim is President and CEO of Advocate Aurora Health. Previously, he served as President and Chief Executive Officer of Advocate Health Care, the largest health system in Illinois and one of the largest in the Midwest, since 2002.

Named as one of the 100 Most Influential People in Healthcare by Modern Healthcare for nine consecutive years beginning in 2011, Jim has been featured in local and national news publications as a leading voice on health care transformation and innovation; national health reform efforts; quality, cost and high reliability initiatives; patient safety; and health care providers’ commitment to serving their communities. Under his leadership, Advocate Aurora Health has been recognized as a national leader for its clinical successes, technological innovation, workplace culture and safety excellence.

He is a former member and past chair of the American Hospital Association (AHA) Board of Directors, the national organization that represents America’s hospitals and health systems. He also is a former chair of the AHA Section for Health Care Systems Governing Council and a member of Regional Policy Board 5. Jim is a member of the World Business Chicago Board of Directors and is a past chair of Chicago United as well as the American Cancer Society’s (ACS) CEOs Against Cancer and the World Presidents Organization. In 2019, Jim was named Chairman of the American Hospital Association Political Action Committee for a two-year term.

Additionally, he is a fellow of the American College of Healthcare Executives and a past chair of the Illinois Hospital Association’s Board of Trustees. He is the recipient of B’nai B’rith’s 2013 National Healthcare Award and 2015 Chicago United Bridge Award.

Terry Shaw

President and CEO, AdventHealth

Bio coming soon.

Carlos A. Migoya

President and CEO, Jackson Health

Carlos A. Migoya has served as CEO of Jackson Health System since May 2011, overseeing one of the nation’s largest and most respected public healthcare networks. Jackson has the distinction of bringing world-class medical care – including the medical school faculty and students from the University of Miami and Florida International University – to a taxpayerowned system that guarantees a single high standard of care for all residents of Miami-Dade County. The system is anchored by Jackson Memorial Hospital, one of the most respected hospitals in Florida. The system also includes three neighborhood community hospitals, Holtz Children’s Hospital/The Women’s Hospital at Jackson Memorial, Jackson Behavioral Health Hospital, the Christine E. Lynn Rehabilitation Center for The Miami Project to Cure Paralysis at UHealth/Jackson Memorial, two nursing homes and a network of urgent care centers, physician practices, and clinics.

In his first year at Jackson, Mr. Migoya led a transformation that reversed years of massive losses, including an $82 million loss in the prior year, and produced a surplus of more than $8 million. It was the first time Jackson produced a surplus since 2006, and the system has earned an annual surplus every year since. At the same time, key indicators of healthcare quality and patient satisfaction improved, proving that public hospital systems need not choose between medical excellence and operational sustainability. In November 2013, he led a successful campaign in which 65 percent of Miami-Dade voters approved the $830 million Jackson Miracle-Building Bond program, which is the cornerstone of a 10-year, $1.8 billion capital plan to renovate, modernize and expand Jackson’s facilities – a program that has been widely successful, expanding Jackson’s footprint throughout Miami-Dade County. In 2020, he led the system through Miami’s role as an epicenter of the COVID-19 pandemic, serving as a key outside advisor to the Florida governor and Miami-Dade mayor. He also led Jackson’s public vaccination program, which resulted in more than 175,000 people receiving the COVID vaccine at Jackson sites - one of the system’s most ambitious, yet successful, public health projects in its history.

Prior to joining Jackson, Mr. Migoya served as City Manager in Miami, successfully tackling the city’s ailing budget issues. Most of Mr. Migoya’s professional life was spent in the banking industry, rising through the ranks over more than 40 years from part-time teller to regional president and CEO at Wachovia and its predecessors. He most recently served as the regional president of Wachovia in North Carolina and the CEO for the Atlantic region, responsible for banking in New Jersey, Connecticut and New York.

He is actively involved in several community organizations, sitting the boards of Florida Chamber of Commerce, the Beacon Council, and the United Way, where he is the immediate past chair. He is also a member of the Florida Council of 100, an organization of business leaders that promotes the economic growth of Florida and the economic well-being of Floridians. He is also a past chairman of the Safety Net Hospitals Alliance of Florida and was the founding chairman of Florida International University’s College of Business Administration’s principal advisory board, as well as a previous board member of Miami Dade College and Downtown Miami Charter School.

Mr. Migoya earned an undergraduate degree in finance and a Master of Business Administration in finance from Florida International University.

Marty Bonick

President and CEO, Ardent Health

Marty Bonick is president and chief executive officer (CEO) of Ardent Health Services. A veteran health care leader, Mr. Bonick has nearly 25 years of experience driving business growth through innovation and quality improvement across a variety of health care settings. With experience in for-profit, non-profit, public, and privately held companies, he has held senior management roles in large tertiary and academic medical centers, multi-site networks of inpatient and outpatient facilities, and physician services organizations.

Prior to his appointment as President and CEO of Ardent, Mr. Bonick was CEO of PhyMed Healthcare Group, a national provider of anesthesia and pain management services. Throughout his tenure, he drove significant growth both organically and through the acquisition and integration of multiple important partners. Before joining PhyMed in 2017, he served as a division president at Community Health Systems, where he led operations for a $4.5 billion portfolio of 36 hospitals, associated clinics, outpatient centers, ambulatory surgery centers, and urgent care operations across six states. While at CHS, he led the integration of 15 new hospitals into his division while experiencing significant volume and EBITDA growth.

Previously, Mr. Bonick was CEO of Jewish Hospital and senior vice president of operations for Jewish Hospital & St. Mary’s Healthcare in Louisville, Kentucky. He began his health care career at Hillcrest HealthCare System in Tulsa, Oklahoma, which was acquired by Ardent Health Services in 2004. Throughout his 11-year tenure at Hillcrest, he held a number of leadership positions, including vice president of operations for Hillcrest Medical Center and CEO of Oklahoma State University Medical Center.

Mr. Bonick is a Fellow in the American College of Healthcare Executives (FACHE). He holds dual master’s degrees from Washington University in St. Louis in Health Care Administration and Information Management, as well as a bachelor of science degree from the University of Illinois. He is a board member and chair-elect of the Federation of American Hospitals.

Dr Stephen Klasko

President and CEO, Jefferson Health

Dr. Stephen Klasko is an advocate for a transformation of health care and higher education. He has been a pioneer in using technology to build health assurance and equity – especially as we emerge from the Covid-19 crisis.

His new books are Un-Healthcare: A Manifesto for Health Assurance, with Hemant Taneja, and Patient No Longer: Why Healthcare Must Deliver the Care Experience that Consumers Want and Expect. His 2018 book is Bless This Mess: A Picture Story of Healthcare in America.

As President and CEO of Philadelphia-based Thomas Jefferson University and Jefferson Health since 2013, he has led one of the nation’s fastest growing academic health institutions based on his vision of re-imagining health care and higher education.

Under his leadership, Jefferson Health expanded from three hospitals to 14. His 2017 merger of Thomas Jefferson University with Philadelphia University created a pre-eminent professional university that includes fashion, design, architecture and health.

In 2020, he was named the first Distinguished Fellow of the World Economic Forum, and co-chairs the WEF Board of Stewards for The Future of the Digital Economy and New Value Creation.

President Klasko has served as dean of two medical colleges, and leader of three academic health enterprises before becoming President and CEO at Jefferson. For three years he has been listed among the Top 100 most influential people by Modern Healthcare - in 2018 he tied for #2.

His work on healthcare in a digital economy includes his 2009 collaboration with Apple Inc on digital media in healthcare, the 2012 building of one of the nation's largest medical simulation centers (CAMLS), and the development at Jefferson of his vision of "healthcare with no address." He is working with several digital health companies on the vision of "health assurance," using new technology to keep people well, instead of waiting to provide sick care.

Dr Gary Kaplan

CEO, Virginia Mason Franciscan Health and SVP, CommonSpirit

Recognized by Modern Healthcare as one of the “50 Most Influential Physician Executives,” Dr. Kaplan’s skills as an innovator have literally established a new industry standard. He’s led the charge with the kind of out-of-the-box thinking that includes adapting Toyota’s production process for the health care industry.

Gary S. Kaplan, MD, FACP, FACMPE, FACPE, has served as chairman and CEO of the Virginia Mason Health System in Seattle since 2000. He is also a practicing internal medicine physician at Virginia Mason. Dr. Kaplan received a degree in medicine from the University of Michigan and is board certified in internal medicine. He is a Fellow of the American College of Physicians (FACP), the American College of Medical Practice Executives (FACMPE) and the American College of Physician Executives (FACPE). He is recognized as one of the most influential physician executives in health care and his skills as an innovator established a new industry standard; He’s led the charge with the out of the box thinking that includes adapting Toyota’s production process to the healthcare industry.

Dr. Kaplan is a founding member of Health CEOs for Health Reform and has held leadership positions with numerous organizations, including the National Patient Safety Foundation, the Medical Group Management Association, and the Washington Healthcare Forum. He is past-chair of the Institute for Healthcare Improvement Board of Directors, current-chair of Lucian Leape Institute for Patient Safety, and previously served as chair of the Seattle Metropolitan Chamber of Commerce Board of Directors. In 2013, Dr. Kaplan was selected for membership in the Institute of Medicine. He has been honored nationally for his leadership, including being named to Modern Healthcare’s “50 Most Influential Clinical Executives” 2020 list (his fifteenth time appearing on this prestigious list).

During Dr. Kaplan's tenure as chairman and CEO, Virginia Mason has received significant national and international praise for its efforts to transform health care, most notably as the leader in adapting the Toyota Production System for health care. Recent honors include being named “Top Hospital of the Decade” by Healthgrades, receiving the “Distinguished Hospital Award for Clinical Excellence™” in 2019 for the eighth consecutive year and the “Outstanding Patient Experience Award” from Healthgrades, among various other awards and honors

Christophe Weber

President and CEO, Takeda

Christophe Weber is President, Chief Executive Officer (CEO) and Representative Director of Takeda Pharmaceutical Company Ltd. He joined the company in April 2014 as Chief Operating Officer, was named President and Representative Director in June 2014, and was subsequently appointed CEO in April 2015. Mr. Weber has focused on Takeda’s R&D transformation and globalization, creating a diverse and inclusive working environment while strengthening its ethical values and corporate governance. Through this transformation, Takeda became one of the leading global biopharmaceutical companies in the world.

Prior to joining Takeda, Mr. Weber spent 20 years at GlaxoSmithKline (GSK), where he held senior leadership roles in Europe, Asia and the United States.

Outside of Takeda, Mr. Weber is member of The Business Council, the World Economic Forum’s International Business Council, the Singapore Economic Development Board’s International Advisory Council, the New York Stock Exchange’s NYSE Board Advisory Council and the MIT CEO Advisory Board. He also serves on the Board of Trustees of Northeastern University.

Mr. Weber holds a doctorate in pharmacy and pharmacokinetics, master’s degrees in pharmaceutical marketing and in accounting and finance and a degree in statistics, from the University of Lyon, France.

Mr. Weber lives in Tokyo with his wife and has two children.

Dr Nate Favini

Chief Medical Officer, Forward

Bio coming soon.

Dr Marc Harrison

President and CEO, Intermountain

Marc Harrison, M.D., president and CEO of Intermountain Healthcare, is a pediatric critical care physician with a proven track record as a top operations executive on a global scale. He is a national and international thought leader on transformation and innovation—ranking in Fortune Magazine’s Top 50 World’s Greatest Leaders in 2019. He also ranked second among Modern Healthcare’s Most Influential Physician Executives and Leaders and tied for second on its list of the 100 Most Influential People in Healthcare in 2018.

Dr. Harrison embraces strategic partnerships and novel collaborations to solve systemic problems and improve lives. Together with Intermountain’s 38,000 employees —who are all called caregivers—he has implemented bold new approaches to improve health, re-define value-based care, and serve people in new ways. Intermountain’s partnerships, pioneering initiatives, and commitment to service are transforming healthcare and bearing fruit for patients and communities.

For example, Intermountain led a partnership of hundreds of hospitals to launch Civica Rx, a not-for-profit generic drug manufacturer and distributor, to make generic medications more available and affordable in hospitals across the nation. Intermountain is also a founding member of the Utah Alliance for the Determinants of Health, which is a collaboration of community partners designed to proactively address forces that affect people’s health well before they come to a clinic or a hospital.

Previously, Dr. Harrison served as CEO of Cleveland Clinic Abu Dhabi, chief of international business development at Cleveland Clinic, and chief medical operations officer.

He received his undergraduate degree from Haverford College, his medical degree from Dartmouth Medical School, completed a pediatric residency and pediatric care fellowship at Intermountain’s Primary Children’s Hospital, and a Master of Medical Management at Carnegie Mellon University.

Dr. Harrison is an all-American triathlete and represented the U.S. at the 2014 World Championships.

Michael Dowling

President and CEO, Northwell Health

Michael Dowling is one of health care’s most influential voices, taking a stand on societal issues such as gun violence and immigration that many health system CEOs shy away from. As president and CEO of Northwell Health, he leads a clinical, academic and research enterprise with a workforce of more than 75,000 and annual revenue of $14 billion. Northwell is the largest health care provider and private employer in New York State, caring for more than two million people annually through a vast network of more than 830 outpatient facilities, including 220 primary care practices, 52 urgent care centers, home care, rehabilitation and end-of-life programs, and 23 hospitals.

Northwell also pursues pioneering research at the Feinstein Institutes for Medical Research and a visionary approach to medical education highlighted by the Zucker School of Medicine, the Hofstra Northwell School of Nursing and Physician Assistant Studies, and one of the nation’s largest medical residency and fellowship programs.

Mr. Dowling’s leadership has been invaluable to Northwell’s consistent expansion and prominence. In 2020, he successfully navigated the health system through the first COVID-19 epicenter in the US, detailing his experiences in Leading Through a Pandemic: The Inside Story of Humanity, Innovation, and Lessons Learned During the COVID-19 Crisis. Overall, Northwell has treated more than 150,000 COVID patients, and the health system utilized a strong innovative culture to expand hospital bed capacity (adding 2,000 beds in two weeks), 3D-print nasal swabs for COVID testing, convert bi-level positive airway pressure (BiPAP) machines into mechanical ventilators and take advantage of its large, integrated health system to “load balance” and transport 810 patients from overrun hospitals to those that had bed capacity. Northwell also kept employees safe, investing in critical personal protective equipment to help those working the front lines, one of whom — Sandra Lindsay — was the first person in the US to receive the historic COVID vaccine in December 2020.

Prior to becoming president and CEO in 2002, Mr. Dowling was the health system’s executive vice president and chief operating officer. Before joining Northwell Health in 1995, he was a senior vice president at Empire Blue Cross/Blue Shield.

Mr. Dowling served in New York State government for 12 years, including seven years as state director of Health, Education and Human Services and deputy secretary to the governor. He was also commissioner of the New York State Department of Social Services. Before his public service career, Mr. Dowling was a professor of social policy and assistant dean at the Fordham University Graduate School of Social Services, and director of the Fordham campus in Westchester County.

Mr. Dowling has been honored with many awards over the years, including his selection as the Grand Marshal of the 2017 St. Patrick's Day Parade in New York City, induction into the Irish America Hall of Fame, the 2012 B’nai B’rith National Healthcare Award, the Ellis Island Medal of Honor, the 2011 Gail L. Warden Leadership Excellence Award from the National Center for Healthcare Leadership and the 2011 CEO Information Technology Award from Modern Healthcare magazine and the Healthcare Information and Management Systems Society.

In 2020, Mr. Dowling received the Deming Cup from the Columbia School of Business and was ranked No. 2 on Modern Healthcare’s 100 Most Influential People in Healthcare, his highest ranking in 13 years appearing on the list. Additional awards include the National Human Relations Award from the American Jewish Committee, the Distinguished Public Service Award from the State University of New York’s Nelson A. Rockefeller College of Public Affairs and Policy, an Outstanding Public Service Award from the Mental Health Association of New York State, an Outstanding Public Service Award from the Mental Health Association of Nassau County, the Alfred E. Smith Award from the American Society for Public Administration, and the Gold Medal from the American Irish Historical Society. He was also ranked No. 44 among large company CEOs in the US and was the nation’s top-ranking health care/hospital CEO on Glassdoor’s Top CEOs in 2019 list.

Mr. Dowling is past chair of the Healthcare Institute and the current chair of the Institute for Healthcare Improvement (IHI). He is a member of the Institute of Medicine of the National Academies of Sciences and the North American Board of the Smurfit School of Business at University College, Dublin, Ireland. He also serves as a board member of the Long Island Association. He is past chair and a current board member of the National Center for Healthcare Leadership (NCHL), the Greater New York Hospital Association (GNYHA), the Healthcare Association of New York State (HANYS) and the League of Voluntary Hospitals of New York. Mr. Dowling was an instructor at the Center for Continuing Professional Education at the Harvard School of Public Health.

Mr. Dowling grew up in Limerick, Ireland. He earned his undergraduate degree from University College Cork (UCC), Ireland, and his master’s degree from Fordham University. He also has honorary doctorates from Queen's University Belfast, University College Dublin, Hofstra University, Dowling College and Fordham University.

Kathy Giusti

Founder MMRF and Co-Chair HBS Kraft Accelerator

Bio coming soon.

Devon Valencia

Chief Information Officer Caresource

Devon Valencia leads all aspects of information technology and informatics within the organization and is responsible for setting the strategy for the company’s systems and technical infrastructure, systems development and information technology operations. She also manages the implementation of system enhancements and serves as the HIPAA security officer to ensure compliance with all applicable provisions.

She has extensive experience working in information technology which has improved the accessibility of technology within the health care industry to increase company agility. Most recently, she worked for Blue Shield of California as the vice president of enterprise program delivery, applications and Medi-Cal technology, providing leadership for the $20 billion company with four million members.

Devon holds a bachelor’s degree in business finance from the University of the Pacific-Eberhardt School of Business. She is a Certified Supply Chain Professional (CSCP), a Project Management Professional (PMP) and she has completed the executive program in leadership from the Stanford University Graduate School of Business. Devon serves as president on the board of directors for the Center for Violence-Free Relationships and was named one of the 50 Most Powerful Women in Tech from the National Diversity Council.

Murielle Beene

Chief Health Informatics Officer Trinity Health

Bio coming soon.

Stuart Archer

CEO Oceans Healthcare

Stuart Archer began his health care career at the bedside, as a nurse’s aide in a skilled nursing facility. From that formative experience he developed a keen understanding and recognition of the struggles many patients, specifically older adults and seniors, endure to manage their illnesses. Since taking the helm at Oceans Healthcare in 2014, he has shepherded a period of unprecedented growth, earning the company designations as one of the 50 fastest-growing companies in North Texas as determined by the Dallas Business Journal and as one of Inc. 5000’s fastest-growing companies in America.

Previously, Archer served as chief operating officer at LifeCare Management Services, a pioneer in long-term acute care. Prior to LifeCare, he served more than a decade as senior vice president of market development for LHC Group, a leading national provider of post-acute care services with 350 locations across 29 states.  

He is passionate about addressing barriers to mental health treatment and what health care organizations need to do to meet the ever-increasing demand for services. Archer is a member of the Board of Trustees of the National Association of Behavioral Healthcare, an advocacy organization committed to working to ensure public policies, laws and regulations that support the needs of people who live with mental and addictive disorders.

Pat Geraghty

CEO Guidewell and Florida Blue

Pat Geraghty is President and Chief Executive Officer of GuideWell, a $20 billion mutual insurance holding company headquartered in Jacksonville, Fla. A mission-driven health solutions enterprise, GuideWell is the parent to a family of forward-thinking companies focused on transforming health care.

GuideWell comprises Florida Blue, the leading health insurance company in Florida; GuideWell Connect, a consumer engagement and marketing firm that includes Onlife Health; GuideWell Health, a health care delivery company; GuideWell Source, a provider of administrative services to federal and state health care programs, including Medicare; PopHealthCare, a population health management company; and WebTPA, a market leading administrator of self-funded employer health plans. GuideWell serves more than 45 million people across 45 states, including more than 5 million individuals in Florida.

Geraghty was the architect of the strategic restructuring that created GuideWell from the foundation of a 75-year-old health insurance company, transforming it into a health solutions organization at the forefront of reimagining the future of health in America. The GuideWell restructuring is considered a model of strategic reinvention and is featured as a capstone business case in the curriculum of Harvard Business School.

A dynamic speaker, Geraghty is considered an expert voice on a range of health care topics including health care reform in the U.S., next-generation payment strategies, innovation in health care and the benefits of wellness and prevention programming.

He has appeared on NBC’s “Meet the Press,” “Fox Business News,” CNBC’s “Closing Bell,” The Wall Street Journal’s “Money Beat,” “PBS Nightly Business Report,” MSNBC’s “Morning Joe” and Bloomberg TV’s “Street Smart” and “Capitol Gains” programs. Geraghty also has been featured on the front page of The New York Times’ Business Day, in The Wall Street Journal, and in many other media outlets.

In addition to serving as an expert source to leading news media, Geraghty is frequently sought after for his insights on important health care policy matters in Washington, D.C. and Tallahassee, Fla.

Geraghty is active in leading professional and community organizations. He is past chair of the Florida Council of 100, a private, non-profit, non-partisan organization of Florida business leaders who advise the state’s governor on how to improve the economic growth of the state and the economic well-being of its residents.

He also serves as a member of the board of the National Institute of Health Care Management (NIHCM), a non-profit organization dedicated to improving the effectiveness, efficiency and quality of America’s health care system; America’s Health Insurance Plans (AHIP); and Tampa Electric Co. (TECO).

In 2016 Geraghty became a member of the Health Governors Community of the World Economic Forum, the international organization for public private cooperation, and a trustee for its Global Challenge Initiative on The Future of Health.

Geraghty holds a Bachelor of Arts degree from Colgate University and a Doctor of Humane Letters, honoris causa, degree from Florida Southern College. He also has completed executive education programs at Harvard University School of Public Health and the Wharton School at the University of Pennsylvania

Sarah Adler

CEO Guidewell and Florida Blue

I am passionate about solving the access crisis in the behavioral health system. I focus on redesign of care delivery systems using data, clinical innovation and technology to increase access to care.

Anne Quinn Young

Brand President MMRF

Bio coming soon.

Richard Saynor

CEO, Sandoz

When Richard Saynor was appointed CEO of Sandoz in 2019, he took on the mission to turn the Novartis generics and biosimilars division into the world’s leading and most valued generics company.

Today, these efforts are well on track. Sandoz reaches 500 million patients a year with its broad portfolio of affordable medicines, including biosimilars and generic cancer therapies, and generates annual sales of USD 10 billion. Richard’s efforts were recognized when he was named Leader of the Year in the 2020 Global Generics & Biosimilars Awards.

Richard has a wealth of experience in the pharmaceutical industry, including at both innovation-driven companies and generics makers. He previously held regional leadership roles at Sandoz between 2005 and 2010. As head of the global organization, he aims to make Sandoz both a market leader and a thought leader on increasing patients’ access to critical medicines.

Pioneering access for patients is what drives us at Sandoz – binding us together and giving us a true sense of direction. I’ve worked across the pharmaceutical industry, but my heart has always been in generics. They make a difference for hundreds of millions of people worldwide by driving patient access to affordable, high-quality healthcare.

Sandoz played a central role in the Novartis response to the COVID-19 pandemic. It was the first company to commit to keeping prices stable for a basket of medicines used to treat coronavirus patients. In addition, Sandoz provided 15 medicines used to treat COVID-19 at zero profit to governments, nongovernmental organizations and other institutional customers in up to 79 low- and middle-income countries.
Richard was behind another important move to improve patient access in July 2020, with the announcement of a joint investment to secure the long-term future of integrated antibiotics manufacturing in Europe. This was the result of intensive efforts by Sandoz to broker an unprecedented cross-sector initiative that will maintain supplies of critical medicines to customers and patients worldwide.

Brian Thompson

CEO, UnitedHealthcare

Brian Thompson was named chief executive officer for UnitedHealthcare in April 2021. Prior to this role, Brian served as chief executive officer of UnitedHealthcare's government programs including Medicare & Retirement, the largest business dedicated to the health and well-being needs of seniors and other Medicare beneficiaries; and Community & State, which proudly serves 6 million Medicaid members in 31 states, plus Washington D.C.

Prior to leading government programs, Brian served as chief executive officer of the Medicare & Retirement organization. Brian joined UnitedHealth Group in 2004 and since then has held numerous leadership positions including chief financial officer for UnitedHealthcare’s Employer & Individual, Community & State and Medicare & Retirement businesses. In addition, he has served as the financial controller for UnitedHealthcare's Employer & Individual business as well as a director in Corporate Development.

Prior to joining UnitedHealth Group, Brian was a practicing CPA at PricewaterhouseCoopers LLP, serving as a manager in the Transaction Advisory Services group of the Audit practice.

Dr. Valerie Leschber

Senior Vice President, Chief Medical Officer, Cone Health

Valerie Leschber, MD, is chief medical officer and senior vice president, Cone Health. Leschber helps establish process and goals to guide Cone Health to ever higher levels of health care quality. Besides setting the stage for continuous improvement, she is also responsible for keeping the organization in constant compliance for regulatory review.

Leschber is medical director of physician and advance practice provider recruiting for Cone Health. She serves as medical director for the Elon University Department of Physician Assistant Studies in Elon, North Carolina.

Most recently, Leschber served as Cone Health’s chief medical information officer.

Leschber joined LeBauer HealthCare, Primary Care in 2003, practicing internal medicine through 2016 and serving as division chief. Leschber was also medical director for Cone Health Medical Group’s Primary Care Division.

Leschber earned a medical degree from The University of Texas Medical School at Houston, and a Bachelor of Science degree at Texas A & M University. She will complete her executive Master of Health Administration from University of Providence this summer.

Leschber is a graduate of the Health Management Academy’s Chief Medical Officer fellowship, Class of 2020. She is an inaugural graduate of the Physician Leadership Academy in 2013, a collaborative between Cone Health and Center for Creative Leadership.

A board-certified internist, Leschber is also board-certified in clinical informatics. She was in the 2015-2016 class of the Disparities Leadership Program associated with the Disparities Solutions Center at Massachusetts General Hospital.

She is a board member of Peacehaven Community Farm, a residential community and sustainable farm for people with intellectual and developmental disabilities.

Leschber is a graduate of the Health Management Academy's Chief Medical Officer Fellowship. She is a member of the inaugural class of the Physician Leadership Academy, a project of Cone Health and the Center for Creative Leadership. (2013)

A board-certified internist, Leschber became board-certified in clinical informatics in 2018. Leschber participated in the 2015-2016 class of the Disparities Leadership Program associated with the Disparities Solutions Center at Massachusetts General Hospital.

She is a board member of Peacehaven Community Farm, a residential community and sustainable farm for people with intellectual and developmental disabilities.

Manish Sapra

MD, Psychiatry, Northwell Health

Manish Sapra, MD, is executive director of the behavioral health service line at Northwell Health. He oversees strategic clinical program development and physician management for all mental health and substance use disorder programs at Northwell. He interacts with site leaders to drive quality improvement and standardize care.

Dr. Sapra joined Northwell in 2017 and previously served in a dual role as director of strategic initiatives for the behavioral health service line and medical director of practice-based care management at Northwell Health Solutions. He oversaw several population health programs, including behavioral health integration in primary care practices. Dr. Sapra has been instrumental in efforts to modernize behavioral health services by developing new ambulatory tele-psychiatry applications, implementing advanced use of data analytics and exploring value-based purchasing arrangements.

Throughout his career, Dr. Sapra has progressively advanced into leadership roles. Prior to joining Northwell, he was associate chief of clinical services for behavioral health and senior director of community psychiatry at the University of Pittsburgh Medical Center (UPMC), where he directed physician management and business development for its ambulatory and acute-care services and medical education programs related to community psychiatry. His passion for improving mental health care started early in his career, immersing himself in working with Pennsylvania’s underserved communities.

Dr. Sapra is the immediate past president of the American Association for Psychiatric Administration and Leadership, a fellow of the American Psychiatric Association and an active member of the Group for Advancement of Psychiatry, a leading psychiatric think tank. He graduated from Seth G. S. Medical College, University of Mumbai. He completed his residency in psychiatry at St. Elizabeth Medical Center in Boston and has a Masters in Medical Management from Carnegie Mellon University.

Dr. Roberta Capp

Vice President of Clinical Operations and Innovations, Blue Cross NC

As Blue Cross and Blue Shield of North Carolina’s (Blue Cross NC) vice president of Clinical Operations and Innovations, Dr. Roberta Capp oversees efforts to improve outcomes and overall population health through stronger collaboration with health-care providers and integrated case management teams.

Dr. Capp completed her medical doctorate at Harvard Medical School. Her post-doctorate work at Harvard, Yale School of Medicine, and University of Colorado School of Medicine focused extensively on emergency and addiction medicine. Capp’s prolific research output has firmly established her reputation as one of the leading experts on care management, population health, and emergency room operations and efficiencies, among other topics.

At Blue Cross NC, Capp has harnessed that expertise to lead the COVID-19 Clinical Operation Task Force and to spearhead efforts to improve treatment and prevention outcomes. Her work aims to enhance efficiency, improve quality, and maximize affordability through the use of artificial intelligence-based modelling, collaborative approaches to case management, and alternative payment methods for patients with high-cost chronic diseases.

Prior to arriving at Blue Cross NC, Capp served on the faculty at Harvard Medical School, Yale School of Medicine, and in the University of Colorado Department of Emergency Medicine. In addition, she served as medical director for Colorado Access Medicaid and the director of Care Transitions and Clinical Program Development at University of Colorado Hospital.

Kate Berry

SVP, Clinical Affairs and Strategic partnerships, AHIP

Kate Berry is Senior Vice President of Clinical Affairs and Strategic Partnerships with America’s Health Insurance Plans (AHIP).  In this role, Ms. Berry oversees programs related to chronic disease prevention and management such as diabetes, asthma, and mental health.  She works to highlight health insurers’ innovative clinical programs.  Ms. Berry has more than 25 years of experience in healthcare.

Prior to joining AHIP, Ms.  Berry was the Chief Executive Officer of National eHealth Collaborative (NeHC), a public-private partnership that worked closely with the Department of Health and Human Services(HHS) and many healthcare stakeholders to encourage widespread adoption of health information technology to improve patient-centeredness and drive greater value.  Major initiatives Ms. Berry led while at NeHC included leveraging health information technology to improve patient engagement, profiling successes and challenges in health information exchange, and creating a widely attended web-based health information technology education program.

Previously, Ms. Berry was Senior Vice President of Surescripts, leading national and state programs to encourage adoption of electronic prescribing and health information exchange.  While at Surescripts, Ms. Berry created the Center for Improving Medication Management and served as its Executive Director.  The Center was founded by the American Academy of Family Physicians, Blue Cross Blue Shield Association, Medical Group Management Association, Humana, Intel, and Surescripts.  The mission of the Center was to improve outcomes of medication management through collaboration among physician practices, pharmacists, payers/employers, and patients.

Ms. Berry had a career in healthcare management consulting and as a non-profit executive.  As a consultant with McManis Associates, Ms. Berry conducted a wide range of strategic planning engagements with healthcare organizations to develop integrated health systems.  At the American Red Cross, Ms. Berry worked directly for the President and CEO serving as her Chief of Staff and Executive Vice President of External Affairs.

Ms. Berry is a member of the Board of Governors at the Patient-Centered Outcomes Research Institute (PCORI).  She holds a Master’s degree in public policy from Duke University and a Bachelor of Arts degree in political science and English from Goucher College in Maryland.

Dr James Fanale

CEO, Care New England

James E. Fanale, MD, currently serves as president and chief executive officer for Care New England. Prior to arriving at Care New England, Dr. Fanale served as senior vice president for system development and chief operating officer at Jordan Hospital in Massachusetts.

Since assuming his leadership role in January 2018, Dr. Fanale has helped to lead CNE through its most challenging days, focusing on rebuilding CNE’s financial foundation, establishing an aggressive strategy for stabilization and growth, and energizing the more than 7,000 staff and clinicians. He has helped achieve extraordinary results by building a high-performing management team and engaging all employees through open, transparent, and regular communication.

With his guidance, CNE has now shifted from incurring significant operating losses to making small, but important financial earnings. This is all being realized with a system-wide focus on quality and patient safety. Through Dr. Fanale’s leadership, other results include the creation of Care New England Medical Group, a unified system of 500 health care providers with expanded access to a wide array of primary care physicians, surgeons, and specialty services.

While at Jordan Hospital, he was responsible for the development of one of the nation's first Medicare Shared Savings Programs – Accountable Care Organizations (ACO). He created and implemented programs involving population health management, was responsible for the overall operations of the system, and assisted in the merger of Jordan Hospital into Beth Israel Medical Center. He also advanced key relationships with health plans and the physician networks to pioneer both the clinical and management aspects of health care in the accountable care environment.

During his tenure here at CNE, he was responsible for developing the Integra ACO, including the establishment of Integra as a Medicaid Accountable Entity (AE), serving more than 140,000 individuals, while generating Medicare savings of more than $30 million over the last four years. In addition, Integra has achieved one of the highest quality ratings awarded by the Centers for Medicare and Medicaid Services (CMS), and continues to outperform all Medicare ACOs across the region.

Dr. Fanale earned his medical degree from Chicago Medical School and completed his residency at UMass Memorial Medical Center. In addition to his leadership role at CNE, he also serves as an associate professor of medicine at the University of Massachusetts Medical School. Dr. Fanale is a fellow in the American College of Physicians and the American Geriatrics Society, and is a past president and chair of the board of the American Geriatrics Society. He is a member of numerous professional organizations, and has served as an advisor or consultant to numerous public and private organizations.

Dr Shantanu Agrawal

Chief Health Officer, Anthem

Shantanu Agrawal was named Chief Health Officer December, 2020. In the role, he reports directly to Anthem CEO Gail K. Boudreaux.

Agrawal oversees Anthem’s enterprise health strategy, to include medical policy and clinical quality, as well as the company’s work to address the social drivers of health, officials said. He also leads Anthem’s community health strategy and the Anthem Foundation.

Agrawal most recently served as president and CEO of the National Quality Forum (NQF), a non-profit organization dedicated to working with members of the healthcare community to drive measurable health improvements. He is also the former Deputy Administrator for the Centers for Medicare & Medicaid Services (CMS) and is a former director of the Center for Program Integrity (CPI).

Agrawal serves on the board of the Grameen Foundation and the Presidential Advisory Council of Brown University’s School of Public Health. He is also an Adjunct Senior Fellow at the Leonard Davis Institute of Health Economics at the University of Pennsylvania and an Associate Clinical Professor of Emergency Medicine at the George Washington University School of Medicine. Agrawal completed his undergraduate education at Brown University, medical education at Weill Medical College of Cornell University, and clinical training in Emergency Medicine at the Hospital of the University of Pennsylvania. He earned his master’s degree in Social and Political Sciences from Cambridge University.

Axel Threlfall

Editor-at-Large, Reuters

Axel Threlfall is Editor-at-Large, Reuters, based in London. Alongside his editorial duties, he hosts high-profile engagements and thought leadership events for and on behalf of Reuters and Thomson Reuters, such as the Newsmaker series and the World Economic Forum news programming in Davos. He was previously Lead European Anchor for Reuters Digital Video. Prior to joining Reuters, Axel spent five years as an anchor for CNBC in London. Before that, he was an editor with The Wall Street Journal in New York and a news reporter for Bloomberg in London. He has also advised businesses and NGOs on their dealings with the international media. Axel is frequently asked to moderate events for international organizations, including the United Nations, the IMF and the OECD. He has a BA in History from Durham University and a postgraduate degree in journalism from City University, London.

Twitter handle is: @Axelthrelfall

David Nash

Founding Dean Emeritus, Jefferson Collage of Population Health

Dr. David B. Nash is the Founding Dean Emeritus, and he remains on the full-time faculty as the Dr. Raymond C. and Doris N. Grandon Professor of Health Policy, at the Jefferson College of Population Health (JCPH). His 11 year tenure as Dean completes 30 years on the University faculty. JCPH is dedicated to developing healthcare leaders for the future.  After voluntarily stepping down as Dean, Jefferson Health asked him to take on some additional responsibilities as “Special Assistant” to the Chief Physician Executive, and a member of the board of our ACO, one of the largest in the nation, effective July 2019.

A board-certified internist, Dr. Nash is internationally recognized for his work in public accountability for outcomes, physician leadership development, and quality-of-care improvement. 

Repeatedly named to Modern Healthcare’s list of Most Powerful Persons in Healthcare, his national activities cover a wide scope.  Dr. Nash is a principal faculty member for quality of care programming for the American Association for Physician Leadership (AAPL) in Tampa, FL.  He served on the NQF Task Force on Improving Population Health and the John M. Eisenberg Award Committee for The Joint Commission.  He also is a founding member of the AAMC-IQ Steering Committee, the group charged with infusing the tenets of quality and safety into medical education.

Dr. Nash has governance responsibilities for organizations in the public and private sectors.  He has chaired the Technical Advisory Group (TAG) of the Pennsylvania Health Care Cost Containment Council (HC4) for more than 20 years and he is widely recognized as a pioneer in the public reporting of outcomes.  Dr. Nash has been a hospital trustee for 20 years.  He served on the Board of Trustees of Catholic Healthcare Partners (now Mercy Partners), in Cincinnati, OH (1998–2008), where he was the inaugural chair of the board committee on Quality and Safety.  He concluded his tenure (2009-2017) on the board of Main Line Health, a four-hospital system in suburban Philadelphia, PA, where he also chaired the board committee on Quality and Safety.  He now serves on the board of the Geisinger Commonwealth School of Medicine (GCSOM). In 2018 he joined the board of the National Investment Center for Senior Housing and Care (NIC) – a national not-for-profit to enable housing choices for elders. Finally, in 2019, he joined the AMGA Foundation Board in Arlington, VA.

In the for-profit sector, he very recently completed nearly a decade as a member of the Board of Directors for Humana, Inc., one of the nation’s largest publically traded healthcare companies.  In 2014 he joined the board of InfoMC, a leading information technology company in suburban Philadelphia.  He is on the health care advisory board for Arsenal Capital Partners in NYC and just joined the board of Tract Manager, a portfolio company of Arsenal.  In late 2018 he joined the board of ANI Pharmaceuticals, a publically traded generic drug manufacturer, headquartered in Baudette, MN.  Finally, he is a board member of FOX Rehab, a portfolio company of Blue Wolf Capital.

Dr. Nash has received many awards in recognition of his achievements.  He received the top recognition award from the Academy of Managed Care Pharmacy (1995), the Philadelphia Business Journal Healthcare Heroes Award (1997), and was named an honorary distinguished fellow of the American College of Physician Executives (now AAPL) in 1998.  In 2006 he received the Elliot Stone Award for leadership in public accountability for health data from NAHDO.  Wharton honored Dr. Nash in 2009 with the Wharton Healthcare Alumni Achievement Award and in 2012 with the Joseph Wharton Social Impact Award. Also in 2012, he received the Philadelphia Business Journal award for innovation in medical education. 

Dr. Nash’s work is well known through his many publications, public appearances, and online column on MedPage Today.  He has authored more than 100 peer-reviewed articles and edited 25 books, including The Quality Solution, Demand Better, and most recently Population Health: Creating a Culture of Wellness (3rd edition).  He was the inaugural Deputy Editor of Annals of Internal Medicine (1984-1989).  Currently, he is Editor-in-Chief of American Journal of Medical Quality, Population Health Management, and American Health and Drug Benefits.

Dr. Nash received his BA in economics (Phi Beta Kappa) from Vassar College; his MD from the University of Rochester School of Medicine and Dentistry and his MBA in Health Administration (with honors) from the Wharton School at the University of Pennsylvania.  While at Penn, he was a former Robert Wood Johnson Foundation Clinical Scholar and Medical Director of a nine-physician faculty group practice in general internal medicine.  He has received honorary doctorates from Salus University in Philadelphia, GCSOM, and the University of Rochester.  Dr. Nash has delivered numerous endowed and named lectures across the country.

Dr. Nash lives in Ardmore, PA, with his wife of 40 years, Esther J. Nash, MD.  They have 3 adult children.  He enjoys tennis, jogging, biking, and yoga.

Andy Plump

President of R&D, Takeda

Andrew Plump, M.D., Ph.D., is the President, Research & Development of Takeda Pharmaceutical Company Limited and serves as a member of the company’s Board of Directors.

Prior to Takeda, Dr. Plump served as Senior Vice President, Research & Translational Medicine, Deputy to the President of R&D at Sanofi, based in Paris, France. Before Sanofi, he served as Vice President, Worldwide Cardiovascular (CV) Research Head at Merck, where he had direct responsibility for CV research, preclinical development and translational sciences.

Dr. Plump received his M.D. from the University of California, San Francisco (UCSF), his Ph.D. in cardiovascular genetics with Dr. Jan Breslow at Rockefeller University and his B.S. from the Massachusetts Institute of Technology (MIT). He completed a residency in Internal Medicine and a fellowship in Medical Genetics at UCSF. Following his clinical training, Dr. Plump trained as a Howard Hughes and Stanley J. Sarnoff postdoctoral fellow with Dr. Marc Tessier-Lavigne at UCSF, concurrently assuming faculty responsibilities as an Adjunct Clinical Instructor in the Department of Medical Genetics.

Dr. Plump lives in Boston with his wife Suzanne and has three children.

Julie Steenhuysen

Health and Science Correspondent, Reuters

News correspondent with deep experience covering health & science topics for Reuters' general news and financial clients.

Stacy Hurt

The Patient Voice

Stacy Hurt, MHA, MBA is an award-winning 20+ year healthcare executive, caregiver to her intellectually and developmentally disabled son, and stage IV colorectal cancer survivor. She has voluntarily served as an advocate for thousands around the world promoting inclusion of the patient voice. As a Patient Consultant, Stacy connects pharma/tech companies and health systems to their end users by sharing her first-hand lived perspective and strategic expertise. Stacy currently serves as one of ten HIMSS digital influencers and on the #TelemedNow thought advisory panel for telehealth expansion. She resides in Pittsburgh, PA with her husband and two sons.

Dr. Patti Doykos

Executive Director of Healthy Equity, BMS

Bio coming soon.

Rebecca Pifer

Reporter, Healthcare Dive

Bio coming soon.

Esther Schorr

EVP, Remedy Health Media

Bio coming soon.

Andrew Schorr

EVP, Remedy Health Media

Andrew Schorr, medical journalist, has been a patient education pioneer since 1984. He is the co-founder of patientpower.info (with his wife of 33 years, Esther), a respected cancer digital media channel devoted to educating and empowering cancer patients worldwide and aggregating data to understand "the patient journey". More than 300,000 cancer patients are reached monthly. Facilitating the growth of non-profit work for patients, Andrew founded The Patient Empowerment Foundation based in Geneva and the US-based Patient Empowerment Network. He was diagnosed with chronic lymphocytic leukemia in 1996. Through his participation in a clinical trial, he achieved a 17-year remission. He was retreated successfully in 2017. In 2011 he was diagnosed with a second cancer, myelofibrosis. An oral "oncogene inhibitor" medicine allows him to live a normal life. Andrew has hosted and helped produce several thousand webcasts, expert interviews and town hall meetings in the US and Europe. He has journalism degrees from the University of North Carolina at Chapel Hill and Columbia University. In 1992 Andrew developed ‘Healthtalk’ – a program of interactive talk shows for chronically ill patients, which later became part of Everdayhealth.com. In 2005 he founded the patientpower.info web site as the home base for independent audio-video programs for patients. Many of the USA’s leading medical centers have supported Patient Power financially - or by donating medical experts’ time for programs. Support also comes from advertising and sponsorships from a variety of healthcare companies. Patient Power always retains editorial control. Andrew is the author of The Web-Savvy Patient: An Insider's Guide to Navigating the Internet When Facing Medical Crisis, published in 2011 by Amazon. He live near San Diego and guides a virtual team across the US and Europe. 

Mandi Bishop

Vice President, Analyst, Gartner Healthcare

As a Vice President Analyst on the Gartner Healthcare Industry research team, Mandi Bishop supports CIOs in developing IT strategies to advance stability, growth and digital transformation in a rapidly evolving market. Ms. Bishop leads the Healthcare and Life Science Digital Transformation & Innovation research key initiative. Her research agenda is focused on transformation to health value management business models, healthcare administration modernization and automation, as well as the integration of clinical and social determinants of health data with administrative data to improve experience, outcomes, and cost. Key technologies and capabilities that align to her coverage include core administration processing solutions (CAPS, commonly referred to as claims engines), clinical data integration (CDI) from electronic health records (EHR), emerging HL7 FHIR interoperability standards, and payment integrity solutions for payers. She additionally addresses automation (RPA as well as intelligent automation) and community resource network management (CRNM) across industry sectors.

Previous experience

Ms. Bishop led the Dell Services (now NTT Data) Health Plan Analytics Innovation practice, where she advised payer executives on achieving business transformation through enterprise data and analytics. At the Blue Cross Blue Shield Association, she managed the Blue Health Intelligence and Inter-Plan Performance data warehouses. For Florida Blue, she established the Delivery System Informatics and Clinical Data Integration programs. She brings significant additional experience and perspective to her payer coverage from the work she has done supporting provider organizations with IT and data initiatives.

Lidia Fonseca

Chief Digital and Technology Officer, Pfizer

Lidia Fonseca is Executive Vice President, Chief Digital and Technology Officer at Pfizer, responsible for developing and implementing an enterprise-wide digital strategy. Lidia leads all digital, data and technology solutions across the company, as well as Learning and Development and Business Process Excellence. 

She spearheads several transformational programs and initiatives to support Pfizer’s purpose of delivering Breakthroughs that Change Patients’ Lives, applying digital capabilities and products including digitizing drug discovery and development; improving health outcomes and patient experiences; improving operational processes through automation and robotics; and delivering powerful insights with advanced data and analytics for better decision-making. 

Lidia led the effort to create Pfizer’s Advanced Analytics Platform that brings together data from Pfizer and external partners as well as tools to model scientific and clinical decisions, patterns and insights. She is also driving initiatives to re-imagine clinical trials through robotics/automation and tech-enabled processes that enhance patient, provider and site experiences, improve selection and recruitment, and reduce clinical trial cycle times.

Lidia led the effort to launch the Pfizer Digital Companion™, a suite of digital products and solutions to deepen engagement between patients and physicians for better outcomes. She recently collaborated to deliver five solutions: Mabu® Wellness Coach for patients (Mabu® is a registered trademark of Catalia Health Inc.), Champix Chatbot to assist with smoking cessation, LivingWith™ app to support patients undergoing cancer treatment and their loved ones, drone medicine delivery in the Dominican Republic to increase patient access to medicines in remote and difficult-to-reach locations, and a partnership with Fitbit to drive timely diagnosis of atrial fibrillation.

She also leads initiatives to empower Pfizer colleagues, simplifying and automating their work with robotics, machine learning, and predictive analytics that enable better and faster decisions, while driving efficiencies. Since 2019, Pfizer has automated 40 percent of approximately 100 million transactions across the company.

In her prior role, Lidia was the Senior Vice President and CIO at Quest Diagnostics, the world’s leading provider of diagnostic information services serving one in three American adults each year, and half the physicians and hospitals in the U.S. She was responsible for technology, informatics and digital solutions. Lidia led the effort to create Quest's innovative Quanum Solutions brand of healthcare IT and data analytics offerings that deliver critical insights to improve quality outcomes and patient care while lowering costs.

In 2020, Lidia became a member of the Fast Company Impact Council and Pfizer was named one of Fast Company magazine’s 100 Best Workplaces for Innovators, which recognizes innovation in technology, research and development, and their employees. She was named a Technology Visionary by the Association of Latino Professionals For America on its 2020 list of the 50 Most Powerful Latinas. She was named a Healthcare Transformer by Medical, Marketing & Media in 2019. In 2018, she was the only diagnostics provider executive to participate in the White House Artificial Intelligence Summit. She received the 2017 Forbes CIO Innovation Award that recognizes Chief Information Officers who lead revenue enhancing innovation efforts. Lidia was a founding member of Synaptic Health Alliance, comprised of leading healthcare companies Aetna, Cognizant,  Humana, MultiPlan, Optum, Quest Diagnostics and UnitedHealthcare, which uses blockchain technology to improve provider data quality and serves as a distributed partnership model to tackle other industry-wide data issues.

Lidia is a member of the Board of Directors of Tegna, Inc. (NYSE: TGNA) and was a member of the Board of Directors of Gannett (NYSE: GCI) from 2014 to 2016. She also was a board member of Q2 Solutions, a joint venture between Quest Diagnostics and IQVIA from 2016 to 2018.  She earned a bachelor’s degree from the University of California, Berkeley and an MBA and Master Business Informatics from Rotterdam School of Management, Erasmus Graduate School of Business. Lidia is married and has two children.

Christina Farr

Principle Investor, Omers Ventures

Bio coming soon.

Samantha Liss

Reporter, Healthcare Dive

Bio coming soon.

Blake Dodge

Healthcare Reporter, Business Insider

Blake Dodge is a senior healthcare reporter at Business Insider, taking readers inside the secretive health ventures of Amazon, Apple, Google, and Microsoft. 

She previously wrote about healthcare and politics at Newsweek, Bloomberg News, and the Center for Public Integrity. 

Blake graduated from the University of North Carolina at Chapel Hill as a Morehead-Cain scholar, where she competed in the 800-meter and mile on the varsity track team, winning All-ACC honors.

Kim Dixon

Lead Editor, Healthcare Dive

Kim Dixon is the Lead Editor for Healthcare and Medtech. She started her journalism career covering the FDA, reported on hospitals and insurers and most recently edited Politico's first health newsletter from Brussels. She spent more than a decade at Reuters covering health and later tax policy. She's a native New Yorker (but not a snob about it!), and lived most of her adult life in DC. She loves C-Span, running through Rock Creek Park and independent bookstores. She has an MPA and MS in journalism and public affairs from Columbia University and a BS from the University of Pennsylvania.

Luisa Charbonneau

CEO, Braven health

Bio coming soon.

Dedi Gilad

CEO & Co-Founder, TytoCare

With over 18 years of leadership positions both in startups as well as global companies, Dedi brings extensive knowledge and hands-on experience in R&D, Marketing and Operations of multi-disciplinary products in the fields of Healthcare IT, Enterprise Systems, Internet and SaaS. Before founding Tyto Care, Dedi was the General Manager at MDG Medical, VP R&D at WorkplaceIQ (acquired by Siterra / Accruent) and VP R&D at Aman Group. Dedi earned an MBA and a B.Sc. in Industrial Engineering from the Tel-Aviv University.

Florence Kariuki

Chief Clinical Officer, Health Recovery Solutions

Bio coming soon.

Dave Pabley

Principal Consultant, Clarabridge

Dave Pabley recently joined Clarabridge as a Principal Consultant on the Strategic Consulting team. Before joining Clarabridge, he worked as a Sr. Director in Optum’s Customer Experience Office where he was responsible for strategy and operations for Clarabridge and Qualtrics, as well as other aspects of VoC. Dave has nearly 12 year’s analytics experience in healthcare, as well as IT management, software development, and program management experience in financial services, semiconductor manufacturing, publishing, and government consulting sectors. He grew up in Kensington, Maryland, and earned a B.S. in Civil Engineering from the University of Maryland. He is PMP-certified, and works from his home in Steamboat Springs, Colorado, where he enjoys skiing, mountain biking, and fly fishing with his wife and their two kids.

Dr Laura Hamill

Chief Science Officer, Limeade

Laura Hamill, Ph.D., is the Chief Science Officer at Limeade, an employee engagement platform that builds great places to work by improving well-being and strengthening workplace culture. As the Founder and Managing Director of the Limeade Institute, which conducts proprietary research, establishes market points of view and keeps a pulse on the latest employee well-being and engagement trends. She earned her Ph.D. in industrial/organizational psychology from Old Dominion University and a B.S. in psychology from the University of North Carolina, Chapel Hill.

Stuart Winters

CEO of Healthcare, Sodexo U.S

Stuart Winters is CEO of Healthcare for Sodexo in the U.S. He was appointed in September 2021 to lead Sodexo’s growing business to deliver patient nutrition, culinary services, infection prevention, healthcare technology management and other essential services for Sodexo’s clients. Previously, Stuart was CEO for Healthcare in the UK & Ireland (2018-2021) and the Asia Pacific (2015-2018) regions. In both of those roles, he expanded Sodexo’s expertise and brought innovative solutions to the market. Under his leadership in the UK & Ireland, he led the effort to make Sodexo the UK’s largest provider of Covid testing centers and grew the company’s Healthcare Technology Management expertise through acquisition. Stuart joined Sodexo in 2005 in Bangkok, where he opened and ran several new countries for Sodexo, including Thailand, the Philippines, Vietnam, Malaysia and Laos. He has worked for Honeywell and global organizations in the Oil and Gas industry before joining Sodexo.

Tom Swanson

Head of Health & Life Sciences Strategy and Marketing, Adobe

Tom brings a decade of experience in the healthcare industry to Adobe, as well as extensive experience in digital transformation. Tom’s role at Adobe includes positioning Adobe in the health and life sciences marketplace, providing thought leadership, enabling the field, and evangelizing the importance of transforming how consumers engage healthcare.

Daniella Foster

Global Vice President and Head of Public Affairs, Science and Sustainability, Bayer

Daniella Foster is the Global Vice President and Head of Public Affairs, Science and Sustainability for Bayer’s Consumer Health Division. In this role, she is responsible for embedding sustainability into the fabric of the divisional business model, including strategy and ambition development, implementation and impact stewardship. This work focuses on empowering the transformation of everyday health for 100 million people in underserved communities around the world by 2030 through health literacy programs, access strategies and planet-friendly packaging.

A policy innovator and social entrepreneur, she has spent her career focused on actionable innovation in the government, business and non-profit sectors. Foster has worked across sectors leading initiatives to develop new brands and categories, grow small businesses, connect entrepreneurs to global supply chains, develop youth job skills and accelerate innovation.

Previously, Foster was the Vice President of Global Corporate Responsibility at Hilton, where she created and implemented programs that positioned Hilton as the industry leader in sustainable travel and tourism, launching its 2030 Goals agenda and securing the top ranking on the Dow Jones Sustainability Index among hospitality companies. Foster previously led global Corporate Affairs and Science Communications for the innovation hub of Mars, Incorporated. She also earned valuable public-sector experience at the U.S. Department of State, where she held roles of increasing responsibility and scope, and owned the Department's partnerships and social innovation agenda.

She is passionate about social entrepreneurship and serves as the Chairwoman of the Emergent Leaders Network, a non-profit she co-founded that provides scholarships and mentoring to community college students.

Foster is a board member of the United Nations Global Compact Network USA and the U.S. Chamber of Commerce Foundation and serves as a Commissioner for the Global Business Coalition Education’s Youth Skills and Innovation Commission.

She holds an M.A. in Social and Public Policy from Georgetown University and a B.A. in Intercultural Communications and Business from Pepperdine University.

Jenny Streets

Head of Facebook Health

Jenny Streets has spent nearly 20 years transforming the healthcare industry, fueled by her passion for using mobile to improve the customer experience. Prior to leading Facebook’s Healthcare sales team, she trailblazed a technology-driven marketing approach at companies such as AstraZeneca, earning her the President’s Award for her pioneering work and digital advancements. Jenny has also been named a Top 40 Healthcare Transformer by MM&M recognized for fulfilling her mission to help pharmaceutical brands innovate in mobile, content, and media. Her extensive background in healthcare marketing, also includes leading roles at, Digitas Health and Pfizer.

Carl O’Donnell

Pharmaceutical Industry Reporter Reuters

Bio coming soon.

Dr Will Caldwell

Senior Vice President, Health Catalyst

Bio coming soon.

Keller Rinaudo

Co-founder and CEO, Zipline

Bio coming soon.

Shannon Muchmore

Shannon Muchmore Senior Editor, Healthcare Dive

Bio coming soon.

Mohana Ravindranath

Senior Healthcare Reporter, Business Insider

Bio coming soon.

Stephen P. MacMillan

Chairman, President and Chief Executive, Hologic

Steve MacMillan was named President and CEO of Hologic, the global leader in women’s health, in December 2013 and appointed Chairman in June 2015. Under his leadership, Hologic, has more than doubled in revenue by expanding its positions in 3-D mammography, molecular diagnostics and gynecological surgical business.

From 2005 to 2012, Mr. MacMillan served as President and Chief Executive Officer of Stryker, where he had been President since 2003.

During his tenure at Stryker, Mr. MacMillan successfully led the company through a series of key strategic acquisitions, the launch of several products within the orthopedic implants and medical instrumentation businesses, and delivered strong operating performance, with revenue tripling from $2.8 billion to $8.3 billion between 2003 and 2011 – helping move the company up over 200 spots on the Fortune 500 list.

In 2000, Mr. MacMillan joined Pharmacia Corporation’s Executive Committee where he oversaw five global businesses with revenues exceeding $2 billion.

Mr. MacMillan began his career with Procter & Gamble in 1985 and later spent 11 years with Johnson & Johnson in both the U.S. and Europe and became President of the joint venture between Johnson & Johnson and Merck.

Mr. MacMillan received a Bachelor of Arts degree in economics from Davidson College and is a graduate of Harvard Business School’s Advanced Management Program.

Currently, Mr. MacMillan serves on the AdvaMed Board of Directors, and the Board of Trustees at Davidson College where he was also captain of the golf team. He also previously served on the Board of Directors of Texas Instruments, Alere and Boston Scientific, and served on the Institute of Medicine’s Healthcare Policy Roundtable.

He was one of the Fortune 500 CEOs appointed to the Department of Commerce’s Advanced Manufacturing Partnership part of a national effort bringing together industry, universities, and the federal government to invest in the emerging technologies that will create high quality manufacturing jobs and enhance our global competitiveness.

Ron Emerson

Global Healthcare Lead, Zoom

Ron Emerson RN BSN is the Global Healthcare Lead at Zoom. He is a former member of the board of Directors for the American Telemedicine Association and Chair of the Industry Council. He has more than 20-years’ experience in the healthcare industry having worked on a number of Telemedicine programs in 46 countries. He is recognized as a thought leader in Telehealth, having developed a variety of innovative telehealth applications, and consulted on telehealth deployments worldwide. He also held the position of Executive Director for a large telemedicine operation in the United States, where he was responsible for the efficient provision of services to 350 sites. Mr. Emerson was the previous recipient of the American Telemedicine Association Industry Council Award for his leadership in the advancement of Telehealth.